Catalyst Wire Dossier Catalyst Wire Dossier

Revasc

desirudin · Canyon Pharmaceuticals Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Revasc, covering 2014-07-29 to 2014-07-29. Get the full timeline:

Most recent: EMA Withdrawn: Revasc (desirudin) — Canyon Pharmaceuticals Ltd.

See pricing